The first ‘Manipal cGMP Forum: National Conference on cGMP & Compliance’, will be a day dealing with the theme “cGMP for Sustainable Quality”, will take place on October 10, 2025 at the Dr TMA Pai Auditorium, MAHE, Manipal.
New data from the HS-OBTAIN phase 2a study (NCT05849922) that has been released today at the EADV 2025 Congress in Paris shows that the investigational therapy brivekimig has most significantly improved the region of skin disease in patients with...
Stryker, a company that is known worldwide for its medical technologies, has made its presence known in India for the research and development area by inaugurating a new facility of 140,000 sq. ft. in Whitefield, Bengaluru.
AstraZeneca announced today positive top-line results from the Phase III TULIP-SC study, assessing the subcutaneous administration of Saphnelo (anifrolumab) in patients with systemic lupus erythematosus (SLE).The interim analysis met the...
The government has planned for a Promotion of Research and Innovation in Pharma MedTech (PRIP) scheme to be rolled out this month.
The World Health Organization (WHO) has introduced the updated guidelines that focus on strengthening HIV service provision, on improving long-term adherence to antiretroviral therapy (ART), and on promoting the overall health
.jpeg){kind=spacer}
Fischer Medical Ventures Ltd (FMV) through its closely associated company Nanyang Biologics (NYB) shares the glory of securing an exceptional partnership with NVIDIA, Hewlett Packard Enterprise (HPE), and Equinix, top global technology
Swiss drugmaker Novartis suffered a major blow as the Indian Patent Office (IPO) stripped off the patent for its heart failure drug Vymada (Entresto internationally) citing it as a lack of novelty and inventive step.
Delhi became the latest Indian states to intensify its crackdowns on counterfeit medicines by forming a special committee under the health department, officials confirmed today. The action follows enhanced concerns over the sale of counterfeit...
.jpeg){kind=spacer}
The Bombay High Court has given an interim injunction to Sun Pharma Laboratories Limited, which will stop Rambo Lifesciences Pvt. Ltd.
.jpg)
, CDSCO.jpg)